Case Study: A 730-Day Enrollment Window, Reshaped Before Day One

A top-10 pharma sponsor's aggressive Phase III cardiovascular timeline, modeled head-to-head against real-world data — surfacing a diversified country mix that cut 118 days to LPI and raised success odds from 85% to 94%.

On-Demand Webinar: Stop Guessing, Start Enrolling

The webinar explores the key limitations and downstream impacts of an oversimplified enrollment forecasting and tracking model. In conversation with leaders from CSL Behring and Merck, we share best practices on how to properly use benchmark studies, model different scenarios based on inputs (not outcomes), diagnose enrollment delays, and choose the right combination of interventions to get enrollment back on track.

Trained, but Not Prepared: The State of Clinical Research Site Training

Sites complete every module and sign every attestation, and still end up learning your protocol through trial and error on real patients. This whitepaper breaks down why legacy LMS and CRO-delivered training can't close that gap, what ICH E6(R3) now expects instead, and what a sponsor-owned approach looks like when it actually works. 

Enrollment Plan Maturity Assessment

Most enrollment plans are built once, hold a single number, and stay untouched until a milestone forces a reckoning. This nine-question self-assessment shows where your forecasting process actually sits — reactive, responsive, predictive, or optimized — and what closes the gap.